Cedric Hermans/institutroialbertdeux.be
Nov 14, 2026, 14:11
Cedric Hermans: Advancing Haemophilia Care Through Innovation and Global Access
Cedric Hermans, Co-Chair FVIII/FIX SSC ISTH 2025, shared a post on LinkedIn:
“How can better science become better lives for more people?
Day 2 of the WFH New Technology and Gene Therapy Workshop in Montreal connected advances in clotting-factor engineering and emerging therapies with equally important questions: patient choice, inclusion of women and girls, long-term safety and global access.
The unique strength of this meeting lies in bringing scientists, clinicians, innovators and patient representatives into the same conversation.
Turning innovation into accessible care remains our shared responsibility.
My Day 2 reflections are attached.”
See more in the gallery.
Stay updated with Hemostasis Today.
-
Nov 14, 2026, 14:08Bruno Pougault: Lupus Anticoagulant Testing During DOAC Therapy
-
Nov 14, 2026, 14:08Francinny Alves Kelly: AHA Scientific Sessions 2026 Features Research on CHA₂DS₂-VASc and Transhepatic AF Ablation
-
Nov 14, 2026, 14:03Newborn Vitamin K Prophylaxis and the Risk of Bleeding – JAMA
-
Nov 14, 2026, 14:03Denis Oduor: Shaping the Future of Transfusion Medicine at Terumo BCT Africa Hackathon 2026
-
Nov 14, 2026, 14:01Maria Elisa Mancuso: Shaping the Future of Hemophilia Care Together!
-
Nov 14, 2026, 13:58Deniz Aslan: Advancing Pediatric Beta-Thalassemia Screening
-
Nov 14, 2026, 13:56ASPERA-R Study Investigates Anticoagulation Timing Following Breakthrough Ischemic Stroke – International Journal of Stroke
-
Nov 14, 2026, 13:47Karen A. Moffat: New 2026 Issue on Laboratory Diagnostics in Thrombosis and Haemostasis
-
Nov 14, 2026, 13:45César Erazo: Investigating Anticoagulation in Secondary Stroke Prevention at AHA 2026